R.PR
REGISTERED-PRINCIPAL REGISTER
09/28/2021
Back to search
Official data from USPTO
ALPHAMEDIX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
37
Latest update
09/28/2021
Trademark type
Word
Nice classes
5
Filing date
01/05/2018
Registration date
09/28/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/28/2021
Last transaction
09/28/2021
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
07/16/2021
First use in commerce
07/16/2021
Drawing code
4
Owner type
03
Owner location
Houston, TX, US
Examiner
CARROLL, DORITT
Law office
M70
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
RadioMedix, Inc.
Representatives
N. Alexander Nolte Nolte Lackenbach Siegel
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical productpharmaceutical preparations for treatment of tumors in cancer patients
Publications
History of USPTO decisions and trademark events.
37 publications found
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/24/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/23/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/21/2021
IUAF
USE AMENDMENT FILED
07/18/2021
EISU
TEAS STATEMENT OF USE RECEIVED
07/18/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/04/2021
EX5G
SOU EXTENSION 5 GRANTED
02/03/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/03/2021
EXT5
SOU EXTENSION 5 FILED
01/19/2021
EEXT
SOU TEAS EXTENSION RECEIVED
01/19/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/21/2020
EX4G
SOU EXTENSION 4 GRANTED
07/17/2020
EXT4
SOU EXTENSION 4 FILED
07/17/2020
EEXT
SOU TEAS EXTENSION RECEIVED
07/17/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/17/2020
EX3G
SOU EXTENSION 3 GRANTED
01/15/2020
EXT3
SOU EXTENSION 3 FILED
01/15/2020
EEXT
SOU TEAS EXTENSION RECEIVED
01/15/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/18/2019
EX2G
SOU EXTENSION 2 GRANTED
07/16/2019
EXT2
SOU EXTENSION 2 FILED
07/16/2019
EEXT
SOU TEAS EXTENSION RECEIVED
07/16/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/01/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/07/2018
EX1G
SOU EXTENSION 1 GRANTED
12/05/2018
EXT1
SOU EXTENSION 1 FILED
12/05/2018
EEXT
SOU TEAS EXTENSION RECEIVED
12/05/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/17/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/22/2018
PUBO
PUBLISHED FOR OPPOSITION
05/22/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/16/2018
DOCK
ASSIGNED TO EXAMINER
04/16/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/19/2018
NWAP
NEW APPLICATION ENTERED
01/09/2018
Continuous trademark protection
Get notified about every new filing that threatens ALPHAMEDIX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.